[{"address1": "9704 Medical Center Drive", "city": "Rockville", "state": "MD", "zip": "20850", "country": "United States", "phone": "301 251 5172", "fax": "301 251 5321", "website": "https://www.macrogenics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule for the treatment of solid tumors, which is in preclinical trials. It is also developing next generation T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.", "fullTimeEmployees": 341, "companyOfficers": [{"maxAge": 1, "name": "Mr. James  Karrels", "age": 58, "title": "Senior VP, CFO & Corporate Secretary", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 663431, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric Blasius Risser", "age": 52, "title": "CEO, President & Director", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 651362, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thomas M. Spitznagel Ph.D.", "age": 58, "title": "Senior Vice President of Technical Operations", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 550974, "exercisedValue": 204497, "unexercisedValue": 490417}, {"maxAge": 1, "name": "Dr. Ezio  Bonvini M.D.", "age": 71, "title": "Senior VP of Research & Chief Scientific Officer", "yearBorn": 1954, "fiscalYear": 2024, "totalPay": 612208, "exercisedValue": 264031, "unexercisedValue": 199063}, {"maxAge": 1, "name": "Mr. Jeffrey Stuart Peters J.D.", "age": 54, "title": "Senior VP, General Counsel & Corporate Compliance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steve  Harig", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harish  Krishnaswamy", "title": "Senior Vice President of Business Development & Portfolio Planning", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Frank George Perabo FEBU, M.D., Ph.D.", "age": 61, "title": "Vice President & Interim Head of Clinical Development", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth  Smith", "age": 57, "title": "VP, Controller & Treasurer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.73, "open": 1.72, "dayLow": 1.69, "dayHigh": 1.72, "regularMarketPreviousClose": 1.73, "regularMarketOpen": 1.72, "regularMarketDayLow": 1.69, "regularMarketDayHigh": 1.72, "payoutRatio": 0.0, "beta": 1.48, "forwardPE": -0.99028933, "volume": 197432, "regularMarketVolume": 197432, "averageVolume": 1290505, "averageVolume10days": 573100, "averageDailyVolume10Day": 573100, "bid": 1.24, "ask": 2.2, "bidSize": 2, "askSize": 2, "marketCap": 107539504, "fiftyTwoWeekLow": 0.99, "fiftyTwoWeekHigh": 2.95, "allTimeHigh": 41.0, "allTimeLow": 0.99, "priceToSalesTrailing12Months": 0.8426144, "fiftyDayAverage": 1.6508, "twoHundredDayAverage": 1.600025, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -1848495, "profitMargins": -0.59459996, "floatShares": 55294283, "sharesOutstanding": 63258532, "sharesShort": 4153716, "sharesShortPriorMonth": 3906299, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.0657, "heldPercentInsiders": 0.03071, "heldPercentInstitutions": 0.64791, "shortRatio": 3.98, "shortPercentOfFloat": 0.0808, "impliedSharesOutstanding": 63258532, "bookValue": 1.059, "priceToBook": 1.605288, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "earningsQuarterlyGrowth": -0.701, "netIncomeToCommon": -75886000, "trailingEps": -1.21, "forwardEps": -1.71667, "enterpriseToRevenue": -0.014, "enterpriseToEbitda": 0.017, "52WeekChange": -0.40209788, "SandP52WeekChange": 0.11527538, "quoteType": "EQUITY", "currentPrice": 1.7, "targetHighPrice": 5.0, "targetLowPrice": 2.0, "targetMeanPrice": 3.4, "targetMedianPrice": 3.0, "recommendationMean": 2.57143, "recommendationKey": "hold", "numberOfAnalystOpinions": 5, "totalCash": 146396992, "totalCashPerShare": 2.314, "ebitda": -106061000, "totalDebt": 37009000, "quickRatio": 4.849, "currentRatio": 5.219, "totalRevenue": 127626000, "debtToEquity": 55.236, "revenuePerShare": 2.025, "returnOnAssets": -0.26525, "returnOnEquity": -0.81132007, "grossProfits": -55846000, "freeCashflow": -124597624, "operatingCashflow": -162468000, "earningsGrowth": -0.704, "revenueGrowth": -0.342, "grossMargins": -0.43758, "ebitdaMargins": -0.83102995, "operatingMargins": 0.25585, "financialCurrency": "USD", "symbol": "MGNX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": -1.21, "epsForward": -1.71667, "epsCurrentYear": -0.885, "priceEpsCurrentYear": -1.920904, "fiftyDayAverageChange": 0.049200058, "fiftyDayAverageChangePercent": 0.029803766, "twoHundredDayAverageChange": 0.09997499, "twoHundredDayAverageChangePercent": 0.06248339, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.6 - Hold", "cryptoTradeable": false, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1771621804, "regularMarketTime": 1771621202, "exchange": "NMS", "messageBoardId": "finmb_600911", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.7341, "regularMarketPrice": 1.7, "shortName": "MacroGenics, Inc.", "longName": "MacroGenics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1381411800000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.7, "postMarketChange": 0.0, "regularMarketChange": -0.03, "regularMarketDayRange": "1.69 - 1.72", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1290505, "fiftyTwoWeekLowChange": 0.71000004, "fiftyTwoWeekLowChangePercent": 0.7171717, "fiftyTwoWeekRange": "0.99 - 2.95", "fiftyTwoWeekHighChange": -1.25, "fiftyTwoWeekHighChangePercent": -0.4237288, "fiftyTwoWeekChangePercent": -40.20979, "earningsTimestampStart": 1773954000, "earningsTimestampEnd": 1773954000, "earningsCallTimestampStart": 1742502600, "earningsCallTimestampEnd": 1742502600, "isEarningsDateEstimate": true, "displayName": "MacroGenics", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]